The present disclosure relates in general to a flexible and non-absorbent vaginal insert device for use in improving symptoms associated with pelvic organ prolapse and urinary incontinence when the device is inserted, and more particularly to a vaginal insert device that is easier to insert and remove.
Stress Urinary Incontinence (SUI) and Pelvic Organ Prolapse (POP) are growing problems globally that not only cost health care systems large amounts of money, but severely degrade the quality of life of tens of millions of women in the United States alone. Although surgical solutions can succeed in ameliorating symptoms associated with SUI and POP, surgery is not without risks and complications and may even leave the patient in a worse situation than before treatment. See Huang W, Wang T, Zong H, Zhang Y, Efficacy and Safety of Tension-Free Vaginal Tape-Secure Mini-Sling Versus Standard Midurethral Slings for Female Stress Urinary Incontinence: A Systematic Review and Meta-Analysis, International Neurourology Journal, 2015, 19(4):246-58, which is incorporated herein by reference. See also Ellington D R, Erekson E A, Richter H E, Outcomes of Surgery for Stress Urinary Incontinence in the Older Woman, Clin Geriatr Med., 2015, 31(4):487-505, which is incorporated herein by reference. The FDA has issued several Public Health Notifications regarding surgical mesh placed through the vagina (transvaginal placement) to treat POP and SUI. The FDA identified serious and frequent complications with surgical mesh, including mesh erosion through the vagina, pain, infection, bleeding, discomfort during intercourse, organ perforation, urinary problems, recurrent prolapse, neuro-muscular problems, vaginal scarring/shrinkage & emotional problems. Most surgical complications require intervention including medical, additional surgical treatment and hospitalization.
Prior art pessaries, which have been most commonly used for management of female POP but also have been used for SUI, have presented a viable non-surgical option for treating SUI and POP. These prior art pessaries have had few complications and side effects. However, these devices are traditionally placed in the vagina for an extended period of time. They may also be uncomfortable. Furthermore, these prior art devices have been difficult for the patient to insert and remove, and use, insertion and removal of these devices have often required regular office visits with a physician for years. See, Jones K A, Harmanli O, Pessary Use in Pelvic Organ Prolapse and Urinary Incontinence, Rev Obstet Gynecol, 2010, 3(1):3-9, which is incorporated herein by reference. Difficulty with self-removal and insertion of the pessary, having the pessary fall out during defecation, and lack of comfort and convenience may be limiting widespread use of the prior art devices.
Stress Urinary Incontinence (SUI) in women, is the involuntary leakage of urine due to a weakened pelvic support system and/or pressure on the bladder from aging, genetics, or childbirth. The Urology Care Foundation estimates that one of every three women will experience SUI at some point in their lifetime. There are a few types of urinary incontinence including stress incontinence, urge incontinence and mixed incontinence. All are mainly due to connective tissue laxity or damage in the vagina or supportive ligaments. See An Integral Theory and Its Method for the Diagnosis and Management of Female Urinary Incontinence, Petros P E, Ulmsten U I, Scand J Urol Nephrol Suppl, 1993, 153, 1-93, which is incorporated by reference.
Connective tissue damage to three zones of the Integral System, which encompasses all three pelvic organs, including the bladder, vagina and ano-rectum, is the ultimate cause of Pelvic Organ Prolapse (POP) and dysfunction in these organs.
Therefore, there is a need for a pessary or other vaginal insert device that manages, improves, or eliminates female incontinence, POP or both incontinence and POP. There is a further need for such a pessary or other vaginal insert device that does not require a prescription, and is non-absorbent, over the counter, convenient, comfortable, and easy for a patient to insert and remove, with no or minimal physician intervention. Preferably such a vaginal insert device would also be reusable, but it also can be disposable.
In accordance with the teachings of the present disclosure, the disadvantages and problems associated with prior art pessaries may be substantially reduced or eliminated.
In accordance with embodiments of the present disclosure, a vaginal insert device for use in improving symptoms associated with pelvic organ prolapse, urinary incontinence, or both pelvic organ prolapse and urinary incontinence can include an upper portion, which is made of an elastic and non-absorbent material, having a cone-shaped body, having a circular transverse cross-section throughout its length, having a wall with an interior side and an exterior side, an upper open end, a lower end, and a hollow interior, wherein the circumference of the upper portion decreases from the upper open end to the lower end, wherein the upper open end of the upper portion is the innermost portion of the vaginal insert device during insertion, and wherein the wall of the upper portion can be squeezed to make the upper portion more compact for easier insertion of the vaginal insert device, and wherein the wall expands back to its original shape after insertion. Such vaginal insert device can further include: an exterior rim surrounding and protruding from the exterior side of the wall of the upper portion and being adjacent to the upper open end; and a plurality of ridges surrounding and protruding from the exterior side of the wall of the upper portion and being spaced apart from the upper open end to the lower end.
In accordance with these and other embodiments of the present disclosure, a vaginal insert device can include a removal portion extending from the lower end of the upper portion, wherein the removal portion can be accessed from the exterior of a vagina when the vaginal insert device is inserted in the vagina, and wherein the removal portion assists in removal of the vaginal insert device from the vagina. The removal portion can comprise a string or a stem. In the embodiment where the removal portion is a stem, the stem can extend from the lower end of the upper portion, wherein the upper portion and the stem comprise an integral one-piece device made from the elastic and non-absorbent material, wherein the stem has a cone-shaped body, having a circular transverse cross-section throughout its length, having a wall, an upper end, a lower open end, and a hollow interior, and wherein the circumference of the stem increases from the upper end to the lower open end. The removal portion can also have a plurality of ridges like the upper portion.
In accordance with these and other embodiments of the present disclosure, a vaginal insert device can include one or more ventilation openings. A ventilation hole can be located at the point where the lower end of the upper portion and a stem intersect. One or more ventilation openings can also be located in the wall on the upper portion.
In accordance with these and other embodiments of the present disclosure, a vaginal insert device can include an exterior rim which is circular and has a first section and a second section, wherein the first section protrudes from the exterior side of the wall of the upper portion a greater distance than the second section.
In accordance with these and other embodiments of the present disclosure, a vaginal insert device can include an applicator used during insertion of the device, wherein the applicator can contain at least the upper portion when it is in a more compact shape, and wherein the applicator assists in the insertion of the device.
Medical and other advantages of the present disclosure may be readily apparent to one skilled in the art from the figures, description and claims included herein. The objects and advantages of the embodiments will be realized and achieved at least by the elements, features, and combinations particularly pointed out in the claims.
It is to be understood that both the foregoing general description and the following detailed description are examples and explanatory and are not restrictive on the claims set forth in this disclosure.
A more complete understanding of the present embodiments and advantages thereof may be acquired by referring to the following description taken in conjunction with the accompanying drawings, in which like reference numbers indicate like features, and wherein:
Preferred embodiments and their advantages are best understood by reference to
The vaginal insert device of the present invention manages, improves, or eliminates female urinary incontinence, Pelvic Organ Prolapse (POP), or both POP and urinary incontinence. It does not require a prescription, and is non-implantable, non-absorbent, over the counter, convenient, flexible, comfortable, and easy for a patient to insert and remove, with no or minimal physician intervention. Preferably such a vaginal insert device would also be reusable, but it also can be disposable. It eliminates concern of Toxic Shock Syndrome (TSS) by not consisting of an absorbency element which could produce odor and breed bacteria. The device of the present invention is fabricated, such as by a molding process, with an elastic and non-absorbent material, preferably a biocompatible elastomer such as medical grade silicone. An example of a silicone material suitable for use in the present invention is NuSil Technology's MED-4950 product, which is characterized as a liquid silicone rubber.
The vaginal insert device of the present invention is shaped so that it is held securely in place in the vagina when inserted, as well as shaped to impose pressure on the urethral sphincter and to support pelvic organs. One exemplary use of the vaginal insert device of the present invention is for management of stress urinary incontinence (SUI) and the involuntary leakage of urine during activities such as coughing, laughing, sneezing, lifting and exercise for patients over the age of eighteen. It is expected that the device will typically be inserted by an adult woman for up to about twelve hours or more, depending on their comfort level.
With reference to
A person of ordinary skill in the art would understand that the vaginal insert device 40 can come in different sizes, including different sizes to accommodate adult women with differing anatomy. Furthermore, a person of ordinary skill in the art would understand that the dimensions of the various sections and portions of the device 40 can be modified from the multiple embodiments illustrated and disclosed herein. For example, referring to
This disclosure encompasses all changes, substitutions, variations, alterations, and modifications to the example embodiments herein that a person having ordinary skill in the art would comprehend. Similarly, where appropriate, the appended claims encompass all changes, substitutions, variations, alterations, and modifications to the example embodiments herein that a person having ordinary skill in the art would comprehend. Moreover, reference in the appended claims to an apparatus, device or system or a component, section, or portion of an apparatus, device or system being adapted to, arranged to, capable of, configured to, enabled to, operable to, or operative to perform a particular function encompasses that apparatus, device, system, or component, whether or not it or that particular function is used, activated, turned on, or unlocked, as long as that apparatus, system, device or component is so adapted, arranged, capable, configured, enabled, operable, or operative.
All examples and conditional language recited herein are intended for pedagogical objects to aid the reader in understanding the disclosure and the concepts contributed by the inventor to furthering the art, and are construed as being without limitation to such specifically recited examples and conditions. Although embodiments of the present disclosure have been described in detail, it should be understood that various changes, substitutions, and alterations could be made hereto without departing from the spirit and scope of the disclosure.
This application is a continuation of U.S. application Ser. No. 15/242,105, filed Aug. 19, 2016, which claims priority to U.S. Provisional Application No. 62/283,092, filed Aug. 20, 2015, the contents of which are hereby incorporated by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
1996242 | Hagedorn | Apr 1935 | A |
2534900 | Chalmers | Dec 1950 | A |
2613670 | Sokolik | Oct 1952 | A |
2638093 | Kulick | May 1953 | A |
2763265 | Waters | Sep 1956 | A |
D222013 | Thomas et al. | Sep 1971 | S |
3626942 | Waldron | Dec 1971 | A |
3845766 | Zoller | Nov 1974 | A |
D250049 | Hite, Jr. | Oct 1978 | S |
4286593 | Place et al. | Sep 1981 | A |
D306347 | Gyurik | Feb 1990 | S |
D323212 | Crawford | Jan 1992 | S |
5782745 | Benderev | Jul 1998 | A |
5827248 | Crawford | Oct 1998 | A |
D430669 | Buck et al. | Sep 2000 | S |
6170484 | Feng | Jan 2001 | B1 |
6413206 | Biswas | Jul 2002 | B2 |
6503190 | Ulmsten et al. | Jan 2003 | B1 |
6558370 | Moser | May 2003 | B2 |
6733438 | Dann et al. | May 2004 | B1 |
6746432 | Zadini et al. | Jun 2004 | B2 |
6770025 | Zunker | Aug 2004 | B2 |
6773421 | Bosselaar et al. | Aug 2004 | B2 |
7577476 | Hochman et al. | Aug 2009 | B2 |
7771344 | Ziv | Aug 2010 | B2 |
7779843 | Astani et al. | Aug 2010 | B2 |
7892163 | Bartning et al. | Feb 2011 | B2 |
D655415 | Chaffringeon | Mar 2012 | S |
D661390 | McLain | Jun 2012 | S |
D661392 | McLain | Jun 2012 | S |
8302608 | Harmanli | Nov 2012 | B2 |
8652026 | Zunker | Feb 2014 | B2 |
8690847 | Norman | Apr 2014 | B2 |
8795248 | Shihata | Aug 2014 | B2 |
D717950 | Agrawal | Nov 2014 | S |
D719653 | Agrawal | Dec 2014 | S |
8911344 | Altan et al. | Dec 2014 | B2 |
8926493 | Karapasha | Jan 2015 | B2 |
9022919 | Ellefson et al. | May 2015 | B2 |
D741479 | Agrawal | Oct 2015 | S |
D746452 | Petrova | Dec 2015 | S |
D760897 | Teo | Jul 2016 | S |
9402703 | Ziv et al. | Aug 2016 | B2 |
9408685 | Hou et al. | Aug 2016 | B2 |
D767759 | McMillon-Nixon | Sep 2016 | S |
10188545 | Conti | Jan 2019 | B2 |
10729464 | Booher, Sr. | Aug 2020 | B1 |
20030149334 | Ulmsten et al. | Aug 2003 | A1 |
20040249238 | Farrell | Dec 2004 | A1 |
20070203429 | Ziv | Aug 2007 | A1 |
20080077097 | Chambers et al. | Mar 2008 | A1 |
20080149109 | Ziv | Jun 2008 | A1 |
20090266367 | Ziv et al. | Oct 2009 | A1 |
20090283099 | Harmanli | Nov 2009 | A1 |
20100145137 | Morgan | Jun 2010 | A1 |
20100312204 | Sheu | Dec 2010 | A1 |
20110295058 | Henriksson et al. | Dec 2011 | A1 |
20120259167 | Karapasha et al. | Oct 2012 | A1 |
20130110060 | Shihata | May 2013 | A1 |
20130138134 | Elman et al. | May 2013 | A1 |
20140000628 | Clark et al. | Jan 2014 | A1 |
20140000629 | Durling et al. | Jan 2014 | A1 |
20140100416 | Durling et al. | Apr 2014 | A1 |
20140100417 | Durling et al. | Apr 2014 | A1 |
20150265456 | Booher, Sr. | Sep 2015 | A1 |
20170049609 | Conti | Feb 2017 | A1 |
20170281325 | Rosen et al. | Oct 2017 | A1 |
20170360594 | Park | Dec 2017 | A1 |
20180344300 | Burrows et al. | Dec 2018 | A1 |
20200078208 | Stoebe-Latham | Mar 2020 | A1 |
Number | Date | Country |
---|---|---|
202009008893 | Jun 2009 | DE |
20 2017 106 300 | Nov 2017 | DE |
0504301 | Mar 2014 | EP |
1064610 | Apr 2007 | ES |
2364645 | Jun 2002 | GB |
6032CHE2015 | May 2017 | IN |
3177410 | Aug 2012 | JP |
30-0707596 | Nov 2013 | KR |
30-0914045 | Jul 2017 | KR |
30-0914047 | Jul 2017 | KR |
101961471 | Mar 2019 | KR |
129391 | Jun 2013 | RU |
2007082341 | Jul 2007 | WO |
2011013954 | Feb 2011 | WO |
2012006670 | Jan 2012 | WO |
2013108249 | Jul 2013 | WO |
2014015975 | Jan 2014 | WO |
2015041353 | Mar 2015 | WO |
2016149317 | Sep 2016 | WO |
2017015767 | Feb 2017 | WO |
2017031456 | Feb 2017 | WO |
Entry |
---|
Written Opinion and International Search Report dated Nov. 17, 2016 in corresponding International Application No. PCT/US2016/047859 (9 pages). |
Huang et al.; “Efficacy and Safety of Tension-Free Vaginal Tape-Secur Mini-Sling Versus Standard Midurethral Slings for Female Stress Urinary Incontinence: A Systematic Review and Meta-Analysis”; International Neurourology Journal, 2015, 19(4): pp. 246-258 (13 pages). |
Ellington et al.; “Outcomes of Surgery for Stress Urinary Incontinence in the Older Woman”; Clin Geriatr Med., Nov. 2015, 31(4): pp. 487-505 (21 pages). |
Petros et al.; An Integral Theory and Its Method for the Diagnosis and Management of Female Urinary Scandinavian Journal of Urology and Nephrology: Suppl No. 153: 1993; pp. 1-93 (93 pages). |
Coelho et al: “Introduction of the method of intravaginal culture (IVC), through the device INVOCell routine laboratory RHA in Brazil”; JBRA Assisted Reproduction 2013; vol. 17 (No. 6): pp. 340-343 (4 pages); published Jan. 2013; doi: 10.5935/1518-0557.20130076. |
Office Action issued in related Chinese Patent Application No. 2016800486873 dated Aug. 27, 2019. |
Extended European Search Report issued in counterpart European Patent Application No. 16837928.7 dated May 7, 2019. |
International Search Report and Written Opinion issued in counterpart International Patent Application No. PCT/US2019/022624 dated Jun. 11, 2019. |
Customer Review of Collapsible Silicone Cup for Sterilizing Your Diva Cup and Storing Menstrual Cups—Foldable for Travel (Amazon.com) Jan. 17, 2018, https://www.amazon.com/review/RJ84O5XNN0ZY9/ref=cm_cr_srp_d_rdp_permie=UTF8&ASIN=B074PBX6ZY. |
Nurse Hatty Kegel Exercise Weight System (Amazon.com) 2016 https://amazon/com/Nurse-Hatty-Exercise-Weight-System/dp/B01FQ21X16/ref=cm_cr_srp_d_product_top?ie= UTF8&th=1. |
Shanna Atnip et al., “Vaginal Support Pessaries: Indications for Use and Fitting Strategies” Urologic Nursing, vol. 32, p. 121, table 4, steps 8-9, May-Jun. 2012. |
Inomata Japanese Rice Washing Bowl with Side and Bottom Drainers, Clear (Amazon.com) 2016, http://www.amazon.com/Inomata-Japanese-Washing-Bottom-Drainers/dp/B004QZAAS2. |
Office Action issued in related Russian Patent Application No. 2018109509 dated Dec. 5, 2019. |
Search Report issued in related Russian Patent Application No. 2018109509 dated Dec. 5, 2019. |
Office Action issued in related Japanese Patent Application No. 2018-528215 dated Jul. 27, 2020. |
First Examination Report dated Feb. 1, 2021, in corresponding Indian Patent Application No. 201817007398 (5 pages). |
Office Action from corresponding U.S. Appl. No. 15/242,105 dated May 17, 2018. |
Office Action from corresponding U.S. Appl. No. 16/355,638 dated May 12, 2021. |
Examination Report from corresponding Australian Application No. 2016308363 dated Jun. 15, 2020. |
Notice of Allowance from corresponding U.S. Appl. No. 15/242,105 dated Nov. 16, 2018. |
Notice of Acceptance from corresponding Australian Application No. 2016308363 dated Aug. 17, 2020. |
Notice of Grant from corresponding Chinese Application No. 2016800486873 dated May 6, 2020. |
Decision to Grant from corresponding Russian Application No. 218109509 dated Mar. 25, 2020. |
Official Notification Prior to Acceptance from corresponding Israeli Application No. 257627 dated Apr. 29, 2021. |
Decision to Grant from Japanese Application No. 2018-528215 dated Mar. 23, 2021. |
Office Action from corresponding EP Application No. 16837928.7 dated Jun. 14, 2021. |
International Search Report and Written Opinion from International Patent Application No. PCT/US2021/033732 dated Oct. 21, 2021, 20 pages. |
Number | Date | Country | |
---|---|---|---|
20190117443 A1 | Apr 2019 | US |
Number | Date | Country | |
---|---|---|---|
62283092 | Aug 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15242105 | Aug 2016 | US |
Child | 16224566 | US |